PYC Therapeutics Limited (ASX:PYC)
Australia
· Delayed Price · Currency is AUD 1.480
-0.020 (-1.33%)
At close: Mar 9, 2026
PYC Therapeutics Revenue
PYC Therapeutics had revenue of 8.90M AUD in the half year ending December 31, 2025, a decrease of -0.06%. This brings the company's revenue in the last twelve months to 20.56M, down -17.73% year-over-year. In the fiscal year ending June 30, 2025, PYC Therapeutics had annual revenue of 23.49M with 6.51% growth.
Revenue (ttm)
20.56M
Revenue Growth
-17.73%
P/S Ratio
70.02
Revenue / Employee
4.11M
Employees
5
Market Cap
1.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 23.49M | 1.44M | 6.51% |
| Jun 30, 2024 | 22.06M | 6.25M | 39.56% |
| Jun 30, 2023 | 15.81M | -236.57K | -1.47% |
| Jun 30, 2022 | 16.04M | 12.97M | 421.83% |
| Jun 30, 2021 | 3.07M | 678.66K | 28.33% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Neuren Pharmaceuticals | 64.65M |
| Clarity Pharmaceuticals | 10.58M |
| Opthea | -20.12K |
| Mesoblast | 98.02M |
| Telix Pharmaceuticals | 1.21B |
| Immutep | 7.92M |
| Clinuvel Pharmaceuticals | 96.30M |
| Racura Oncology | 3.48M |